Per- and polyfluoroalkyl substances (PFAS) in breast milk and infant formula: A global issue

Judy S LaKind1, Josh Naiman2, Marc-Andre Verner3

  • 1LaKind Associates, LLC, 106 Oakdale Avenue, Catonsville, MD 21228, USA; Department of Epidemiology and Public Health, University of Maryland School of Medicine, 655 W Baltimore St, Baltimore, MD, 21201, USA.

Environmental Research
|December 18, 2022
PubMed

Insights

Per- and polyfluoroalkyl substances (PFAS) in breast milk often exceed safe levels for infants. Infant formula may not lower exposure, highlighting the need for better monitoring and informed infant nutrition decisions.

Area of Science:

  • Environmental Health
  • Toxicology
  • Pediatrics

Background:

  • Per- and polyfluoroalkyl substances (PFAS) transfer from mothers to infants via breastfeeding, posing risks during a vulnerable developmental period.
  • Infants can also be exposed to PFAS through the consumption of infant formula.
  • Previous research indicated that four specific PFAS frequently exceeded ATSDR children's drinking water screening levels in breast milk across U.S. and Canadian populations.

Purpose of the Study:

  • To compare global PFAS measurements in breast milk and infant formula against established children's drinking water screening values.
  • To assess infant exposure risks from both breastfeeding and formula feeding.
  • To inform decisions regarding infant nutrition in the context of PFAS contamination.

Main Methods:

  • Focused on four key PFAS: PFOA, PFOS, PFHxS, and PFNA, for which ATSDR has established children's drinking water screening values.
  • Conducted a literature review of published studies on PFAS levels in breast milk and infant formula using PubMed.
  • Compared identified PFAS concentrations with ATSDR children's drinking water screening values.

Main Results:

  • Concentrations of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in breast milk frequently surpassed children's drinking water screening values globally.
  • Available data on infant formula suggests it does not consistently reduce PFAS exposure, particularly when reconstituted with contaminated water.
  • Determining if infant PFAS exposures exceed safe levels is currently challenging for the general public.

Conclusions:

  • Pregnant and lactating women, especially those in contaminated areas, require data for informed infant nutrition choices.
  • There is a critical need for international monitoring of PFAS in breast milk, formula, and drinking water.
  • Developing effective strategies to reduce infant exposure to emerging PFAS is essential, underscoring the importance of this research.
Abstract